RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Eupatilin Ameliorates Collagen Induced Arthritis

      한글로보기

      https://www.riss.kr/link?id=A104768886

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Eupatilin is the main active component of DA-9601, an extract from Artemisia. Recently,eupatilin was reported to have anti-inflammatory properties. We investigated the antiarthriticeffect of eupatilin in a murine arthritis model and human rheumatoidsy...

      Eupatilin is the main active component of DA-9601, an extract from Artemisia. Recently,eupatilin was reported to have anti-inflammatory properties. We investigated the antiarthriticeffect of eupatilin in a murine arthritis model and human rheumatoidsynoviocytes. DA-9601 was injected into collagen-induced arthritis (CIA) mice. Arthritisscore was regularly evaluated. Mouse monocytes were differentiated into osteoclasts wheneupatilin was added simultaneously. Osteoclasts were stained with tartrate-resistant acidphosphatase and then manually counted. Rheumatoid synoviocytes were stimulated withTNF-α and then treated with eupatilin, and the levels of IL-6 and IL-1β mRNA expression insynoviocytes were measured by RT-PCR. Intraperitoneal injection of DA-9601 reducedarthritis scores in CIA mice. TNF-α treatment of synoviocytes increased the expression ofIL-6 and IL-1β mRNAs, which was inhibited by eupatilin. Eupatilin decreased the numberof osteoclasts in a concentration dependent manner. These findings, showing thateupatilin and DA-9601 inhibited the expression of inflammatory cytokines and thedifferentiation of osteoclasts, suggest that eupatilin and DA-9601 is a candidateanti-inflammatory agent.

      더보기

      참고문헌 (Reference)

      1 van Vollenhoven RF, "Treatment of rheumatoid arthritis : state of the art 2009" 5 : 531-541, 2009

      2 Choy EH, "The problem of choice : current biologic agents and future prospects in RA" 9 : 154-163, 2013

      3 Weaver CT, "Th17:an effector CD4 T cell lineage with regulatory T cell ties" 24 : 677-688, 2006

      4 Guerne PA, "Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis" 83 : 585-592, 1989

      5 Wruck CJ, "Role of oxidative stress in rheumatoid arthritis : insights from the Nrf2-knockout mice" 70 : 844-850, 2011

      6 Shakibaei M, "Resveratrol-mediated SIRT-1interactions with p300 modulate receptor activator of NF-kappaB ligand(RANKL)activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells" 286 : 11492-11505, 2011

      7 Xuzhu G, "Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function" 71 : 129-135, 2012

      8 Takayanagi H, "Osteoimmunology and the effects of the immune system on bone" 5 : 667-676, 2009

      9 Khanna D, "Natural products as a gold mine for arthritis treatment" 7 : 344-351, 2007

      10 Park BB, "Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells" 34 : 875-885, 2013

      1 van Vollenhoven RF, "Treatment of rheumatoid arthritis : state of the art 2009" 5 : 531-541, 2009

      2 Choy EH, "The problem of choice : current biologic agents and future prospects in RA" 9 : 154-163, 2013

      3 Weaver CT, "Th17:an effector CD4 T cell lineage with regulatory T cell ties" 24 : 677-688, 2006

      4 Guerne PA, "Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis" 83 : 585-592, 1989

      5 Wruck CJ, "Role of oxidative stress in rheumatoid arthritis : insights from the Nrf2-knockout mice" 70 : 844-850, 2011

      6 Shakibaei M, "Resveratrol-mediated SIRT-1interactions with p300 modulate receptor activator of NF-kappaB ligand(RANKL)activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells" 286 : 11492-11505, 2011

      7 Xuzhu G, "Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function" 71 : 129-135, 2012

      8 Takayanagi H, "Osteoimmunology and the effects of the immune system on bone" 5 : 667-676, 2009

      9 Khanna D, "Natural products as a gold mine for arthritis treatment" 7 : 344-351, 2007

      10 Park BB, "Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells" 34 : 875-885, 2013

      11 Lee SH, "Inhibitory effect of eupatilin and jaceosidin isolated from Artemisia princeps in IgE-induced hypersensitivity" 7 : 1678-1684, 2007

      12 Wong CP, "Induction of regulatory T cells by green tea polyphenol EGCG" 139 : 7-13, 2011

      13 Oh TY, "Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract" 11 : 7450-7456, 2005

      14 Ichikawa H, "Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation" 12 : 662-668, 2006

      15 Ahmad SF, "Grape seed proanthocyanidin extract has potent anti-arthritic effects on collagen-induced arthritis by modifying the T cell balance" 17 : 79-87, 2013

      16 Zheng Y, "Foxp3 in control of the regulatory T cell lineage" 8 : 457-462, 2007

      17 Coffer PJ, "Forkhead-box transcription factors and their role in the immune system" 4 : 889-899, 2004

      18 Bartok B, "Fibroblast-like synoviocytes : key effector cells in rheumatoid arthritis" 233 : 233-255, 2010

      19 Firestein GS, "Evolving concepts of rheumatoid arthritis" 423 : 356-361, 2003

      20 Brennan FM, "Evidence that cytokines play a role in rheumatoid arthritis" 118 : 3537-3545, 2008

      21 Choi EJ, "Eupatilin protects gastric epithelial cells from oxidative damage and down-regulates genes responsible for the cellular oxidative stress" 25 : 1355-1364, 2008

      22 Choi EJ, "Eupatilin inhibits lipopolysaccharide-induced expression of inflammatory mediators in macrophages" 88 : 1121-1126, 2011

      23 Kim YD, "Eupatilin inhibits T-cell activation by modulation of intracellular calcium flux and NF-kappaB and NF-AT activity" 108 : 225-236, 2009

      24 Bottini N, "Duality of fibroblast-like synoviocytes in RA : passive responders and imprinted aggressors" 9 : 24-33, 2013

      25 양희정, "Determination of five active compounds in Artemisia princeps and A. capillaris based on UPLC-DAD and discrimination of two species with multivariate analysis" 대한약학회 37 (37): 617-625, 2014

      26 Choi SC, "DA-9601, a standardized extract of Artemisia asiatica, blocks TNF-alpha-induced IL-8 and CCL20 production by inhibiting p38 kinase and NF-kappaB pathways in human gastric epithelial cells" 12 : 4850-4858, 2006

      27 Seol SY, "DA-9601 for erosive gastritis : results of a double-blind placebo-controlled phase III clinical trial" 10 : 2379-2382, 2004

      28 Brand DD, "Collagen-induced arthritis" 2 : 1269-1275, 2007

      29 Zhu J, "CD4 T cells: fates, functions, and faults" 112 : 1557-1569, 2008

      30 Yeon JT, "Anti-osteoclastogenic activity of praeruptorin A via inhibition of p38/Akt-c-Fos-NFATc1 signaling and PLCgammaindependent Ca2+ oscillation" 9 : e88974-, 2014

      31 Morinobu A, "(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice" 58 : 2012-2018, 2008

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 SCI 등재 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.48 0.37 1.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.85 0.75 0.691 0.11
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼